MENU
INBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inhibrx Biosciences (INBX) Earnings Date & Reports

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

A.I. Advisor
published Earnings

INBX is expected to report earnings to fall 44.64% to -154 cents per share on August 19

Inhibrx Biosciences INBX Stock Earnings Reports
Q2'25
Est.
$-1.55
Q1'25
Missed
by $1.39
Q4'24
Missed
by $1.65
Q3'24
Missed
by $1.36
Q2'24
Beat
by $127.00
The last earnings report on May 14 showed earnings per share of -279 cents, missing the estimate of -140 cents. With 1.43K shares outstanding, the current market capitalization sits at 201.50M.
View a ticker or compare two or three
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in researching and developing biotechnology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
172
Web
https://www.inhibrx.com